– Treatment of cancer at all stages (early, locally advanced and advanced) through Phase I, II and III cooperative clinical trials and studies in adjuvant, neoadjuvant and advanced disease treatment.
– Supportive care and quality of life of the oncology patient
– Epidemiology and prevention of tumor pathology in our field.
– Translational studies for the detection of actionable molecular alterations and mechanisms of resistance to different cancer therapies.
– REGISTRY study within the GEICO group (Spanish Gynecologic Cancer Research Group) in collaboration with the National Biobank Network to obtain samples associated with clinical and disease progression data in women with ovarian-peritoneal trompa-primitive, uterine, cervical and gestational trophoblastic neoplasia cancers.
– Factors related to the response to immunotherapy of neoplasms.

• JOSÉ IGNACIO CHACÓN LÓPEZ-MUÑIZ
• ANA MARÍA GONZÁLEZ AGEITOS
• IGNACIO GARCÍA ESCOBAR
• CARMEN ESTEBAN ESTEBAN
• ICIAR GARCÍA CARBONERO
• JESÚS ANDRADE SANTIAGO
• ANA MARÍA GARCÍA TAPIADOR
• IRENE OTERO SANZ
• ANA BELEN RUPÉREZ BLANCO
• JUAN DAVID CÁRDENAS
• LOURDES FERNÁNDEZ FRANCO
• RUTH ALVAREZ CABELLOS
• ANA KARINA SANTOS
• JAVIER MEDINA MARTÍNEZ